Clinical Trial Update: Microbiome Immunotherapy Neoadjuvant Assessment

View source ↗

Summary

The University College Cork-sponsored trial is evaluating microbiome-based immunotherapy as neoadjuvant treatment for triple-negative breast cancer and is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Microbiome immunotherapy

Snippet

Sponsor: University College Cork | Conditions: Triple Negative Breast Cancer | Status: RECRUITING